language English
Dergi

ESMO OPEN

1 yayın · 2 atıf

Yayınlar
Başlık Yıl Yazar Atıf
Pembrolizumab with trastuzumab and chemotherapy for HER2-positive advanced gastric cancer: health-related quality-of-life analysis from the randomized KEYNOTE-811 trial
2025 Janjigian, Y. Y., Kawazoe, A., Xu, J. +12 2